Loading page
Skip to content

About

At Brixton, we’re pioneering a new approach to pain.

We are a life sciences company developing a first-in-class, nerve-selective biomaterial designed to interrupt pain signals at the nerve level. Our flagship product, Reneurx™ Nerve-Selective Therapy, is an injectable designed to provide months of targeted musculoskeletal pain relief with a single treatment.

Our mission is only possible because of the people behind it. We’re a team united in ensuring that every decision we make is rooted in intention, integrity, and doing what’s best for the patients we serve.

Who We Are

The Brixton Team

Sameer Sabir Chief Executive Officer
Charles Sidoti Chief Technology Officer
Benjamin de la Cretaz Chief Financial Officer
David Acheson Chief Commercial Officer
Brian Newkirk Chief Business Officer
Christie Blakely Vice President, Commercial Development
Thomas Merrill, PhD Vice President, Research
David Curd Vice President, Clinical Operations
Hailey Rooney Vice President, Quality and Regulatory Affairs
Jerry Panos Vice President, Manufacturing and Supply Chain
Sarah Lyon Vice President, Health Economics and Market Access

Board of Directors

Sameer Sabir Chief Executive Officer
Ted Henderson CEO of Schooner Capital
John Maraganore, PhD Co-CEO of Corsera Health
Brent Saunders Former Chairman & CEO of Bausch & Lomb
Elton Brand Former NBA All Star and 17 Year NBA Career
Reggie Groves Medical Device Leader
Bill McCullen Chief Investment Officer of Launch Capital
Karim Maasarani General Partner at Eckuity Capita

Scientific Advisory Board

Brian Cole, MD Acting Chair of the Department of Orthopedics and Section Head of the Cartilage Research and Restoration Center at Rush
Bill Hozack, MD Walter Annenberg Professor of Joint Replacement Surgery at Thomas Jefferson University
Ayesha Abdeen, MD Chief of Hip and Knee Arthroplasty at Boston Medical Center
Maxim S Eckman, MD Professor and Chair of the Department of Anesthesiology and the Ramamurthy Professor in Pain Medicine at UT Health Science Center at San Antonio

Brixton Co-Founders

Rox Anderson, MD Scientific co-founder of Brixton Biosciences and Director of the Wellman Center for Photomedicine at Massachusetts General Hospital
Lilit Garibyan, MD Scientific co-founder of Brixton Biosciences, Associate Professor of Dermatology at Harvard Medical School, and Physician-Scientist at Wellman Center for Photomedicine at Massachusetts General Hospital
Michael Fishman with his family.

In Memoriam

Michael A. Fishman, MD, MBA

We remember and honor Dr. Michael Fishman, our former Chief Medical Officer, whose leadership, expertise, and character deeply shaped Brixton Biosciences and the advancement of Reneurx™ Nerve-Selective Therapy.

We are grateful for the many contributions he made to Brixton and for the lasting influence he had on our science and the growth of our pipeline, and to our culture and the people who had the privilege of working alongside him. His dedication to the promise of our work will remain an important part of Brixton’s legacy as we continue our mission in helping patients live better, pain-free lives.